行情

BDSI

BDSI

BioDelivery科学国际
NASDAQ

实时行情|Nasdaq Last Sale

3.530
+0.020
+0.57%
盘后: 3.530 0 0.00% 16:00 03/27 EDT
开盘
3.460
昨收
3.510
最高
3.640
最低
3.410
成交量
107.14万
成交额
--
52周最高
7.21
52周最低
2.850
市值
3.40亿
市盈率(TTM)
-18.4817
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测BDSI价格均价为7.93,最高价位9.00,最低价为6.00。

EPS

BDSI 新闻

更多
  • BioDelivery Sciences Strong As Ever But At Half The Price
  • Seeking Alpha - Article · 2天前
  • Edited Transcript of BDSI earnings conference call or presentation 12-Mar-20 8:30pm GMT
  • Thomson Reuters StreetEvents · 4天前
  • The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
  • Benzinga · 03/18 11:36
  • Bully For BioDelivery Sciences
  • Seeking Alpha - Article · 03/16 17:49

所属板块

制药
-0.41%
制药与医学研究
-0.87%

热门股票

代码
价格
涨跌幅

BDSI 简况

BioDelivery Sciences International, Inc. is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications of approved therapeutics to address unmet medical needs using drug delivery technologies. The Company develops pharmaceutical products aimed principally in the areas of pain management and addiction. The Company's products utilize the BioErodible MucoAdhesive (BEMA) drug delivery technology, a small, erodible polymer film for application to the buccal mucosa (the lining inside the cheek). The Company's United Sates Food and Drug Administration (FDA) approved product, ONSOLIS (fentanyl buccal soluble film), as well as its approved products BUNAVAIL (buprenorphine and naloxone buccal film) buccal film and BELBUCA (buprenorphine) buccal film, utilize BEMA technology.
展开

微牛提供BioDelivery Sciences International, Inc.(NASDAQ-BDSI)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的BDSI股票新闻,以帮助您做出投资决策。